Alyeska Investment Group
HLVX

Alyeska Investment Group’s HilleVax HLVX Stock Holding History

Alyeska Investment Group’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-39,265
Closed -$630K – 529
2023
Q4 		$630K Sell
39,265
-13,235
-25% -$176K ﹤0.01% 424
2023
Q3 		$706K Buy
+52,500
New +$739K ﹤0.01% 436
2022
Q3 		– Sell
-42,312
Closed -$462K – 427
2022
Q2 		$462K Buy
+42,312
New +$502K 0.01% 534

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group's HLVX Position: Q1 2024 in Review

Alyeska Investment Group sold out of HilleVax (HLVX) in Q1 2024, closing a stake of 39,265 shares — an estimated $630K sold.

Alyeska Investment Group first reported a position in HLVX in Q2 2022 and held it in 3 quarters. The position peaked at $706K in Q3 2023. 81 funds tracked by Wall St. Rank hold HLVX as of Q1 2024.

  • Alyeska Investment Group reported no remaining HilleVax position as of Q1 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 39,265 HilleVax shares in Q1 2024, an estimated $630K.
  • Alyeska Investment Group first reported a position in HilleVax in Q2 2022 and held it in 3 quarters.
  • Alyeska Investment Group's HilleVax position peaked at $706K in Q3 2023.
  • 81 funds tracked by Wall St. Rank held HilleVax as of Q1 2024.

Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.